These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical efficacy of zolmitriptan in migraine]. Leira R; Noya M Neurologia; 1998 Oct; 13 Suppl 2():16-24. PubMed ID: 9859691 [TBL] [Abstract][Full Text] [Related]
4. Zolmitriptan (Zomig) nasal spray for migraine. Med Lett Drugs Ther; 2004 Jan; 46(1174):7-8. PubMed ID: 14726853 [No Abstract] [Full Text] [Related]
5. No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis. Gillotin C; Bagnis C; Mamet JP; Peck RW; Deray G Int J Clin Pharmacol Ther; 1997 Nov; 35(11):522-6. PubMed ID: 9401835 [TBL] [Abstract][Full Text] [Related]
6. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Evers S; Rahmann A; Kraemer C; Kurlemann G; Debus O; Husstedt IW; Frese A Neurology; 2006 Aug; 67(3):497-9. PubMed ID: 16775229 [TBL] [Abstract][Full Text] [Related]
10. Zolmitriptan for migraine. Med Lett Drugs Ther; 1998 Feb; 40(1021):27-8. PubMed ID: 9505961 [No Abstract] [Full Text] [Related]
11. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial. Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M; Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608 [TBL] [Abstract][Full Text] [Related]
12. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study. Gawel M; Aschoff J; May A; Charlesworth BR; Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607 [TBL] [Abstract][Full Text] [Related]
13. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients]. Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773 [TBL] [Abstract][Full Text] [Related]
16. Almotriptan and zolmitriptan in the acute treatment of migraine. Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263 [TBL] [Abstract][Full Text] [Related]
17. Part IV: effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: a post-marketing surveillance study in Germany. Diener HC; Gendolla A Curr Med Res Opin; 2005; 21 Suppl 3():S18-24. PubMed ID: 16083520 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Chen LC; Ashcroft DM Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569 [TBL] [Abstract][Full Text] [Related]
19. Zolmitriptan provides effective migraine relief in adolescents. Linder SL; Dowson AJ Int J Clin Pract; 2000 Sep; 54(7):466-9. PubMed ID: 11070573 [TBL] [Abstract][Full Text] [Related]
20. Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet. Dowson AJ; Almqvist P Curr Med Res Opin; 2005; 21 Suppl 3():S13-7. PubMed ID: 16083519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]